Claims for Patent: 9,642,842

Summary for Patent: 9,642,842

Title:	Opioid receptor ligands and methods of using and making same
Abstract:	This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.
Inventor(s):	Yamashita; Dennis (Cambridge, MA), Gotchev; Dimitar (Hatboro, PA), Pitis; Philip (North Wales, PA), Chen; Xiao-Tao (Furlong, PA), Liu; Guodong (Jamison, PA), Yuan; Catherine C. K. (King of Prussia, PA)
Assignee:	Trevana, Inc. (King of Prussia, PA)
Application Number:	15/093,315
Patent Claims:	1. A method of treating pain in a subject, the method comprising parenterally administering to the subject a pharmaceutical composition comprising a compound having a formula of ##STR00226## or a pharmaceutically acceptable salt thereof. 2. The method of claim 1, wherein the compound has a formula of ##STR00227## or a pharmaceutically acceptable salt thereof. 3. The method of claim 1, wherein the compound has a formula of ##STR00228## or a pharmaceutically acceptable salt thereof. 4. The method of claim 1, wherein the parenteral administration is an intravenous administration. 5. The method of claim 1, wherein the parenteral administration is an intraperitoneal administration. 6. The method of claim 1, wherein the parenteral administration is an intravesical administration. 7. The method of claim 1, wherein the parenteral administration is an intrathecal administration. 8. The method of claim 1, wherein the pain is post-operative pain. 9. The method of claim 1, wherein the pain is neuropathic pain. 10. The method of claim 1, wherein the pain is inflammation pain. 11. The method of claim 1, wherein the pain is trauma pain. 12. The method of claim 1, wherein the pharmaceutical composition is administered in a unit dosage form. 13. The method of claim 1, wherein the pharmaceutical composition comprises 0.15 mg to 4 mg of the compound, or a pharmaceutically acceptable salt thereof. 14. The method of claim 1, wherein the pharmaceutical composition comprises 0.1 mg to 200 mg of the compound, or a pharmaceutically acceptable salt thereof. 15. The method of claim 1, wherein the pharmaceutical composition comprises about 0.01 mg to about 250 mg of the compound, or a pharmaceutically acceptable salt thereof. 16. The method of claim 1, wherein the method comprises administering separate doses of the pharmaceutical composition. 17. The method of claim 1, wherein the method further comprises administering to the subject a non-opioid analgesic. 18. The method of claim 17, wherein the non-opioid analgesic is a non-steroidal anti-inflammatory agent. 19. The method of claim 17, wherein the non-opioid analgesic is aspirin, ibuprofen, diclofenac, naproxen, benoxaprofen, flurbiprofen, fenoprofen, flubufen, ketoprofen, indoprofen, piroprofen, carprofen, oxaprozin, pramoprofen, muroprofen, trioxaprofen, suprofen, aminoprofen, tiaprofenic acid, fluprofen, bucloxic acid, indomethacin, sulindac, tolmetin, zomepirac, tiopinac, zidometacin, acemetacin, fentiazac, clidanac, oxpinac, mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, tolfenamic acid, diflurisal, flufenisal, piroxicam, sudoxicam, isoxicam, or pharmaceutically acceptable salts thereof. 20. A method of treating pain in a subject, the method comprising: a) parenterally administrating to the subject a first dose of a pharmaceutical composition comprising 0.15 mg to 4 mg of a compound having a formula of ##STR00229## or a pharmaceutically acceptable salt thereof; and b) parenterally administrating a second dose of a pharmaceutical composition comprising about 0.01 mg to about 250 mg of a compound having a formula of ##STR00230## or a pharmaceutically acceptable salt thereof. 21. The method of claim 20, wherein the second dose of the pharmaceutical composition comprises 0.15 mg to 4 mg of the compound, or a pharmaceutically acceptable salt thereof. 22. The method of claim 20, wherein the method further comprises administering to the subject a non-opioid analgesic. 23. The method of claim 22, wherein the non-opioid analgesic is a non-steroidal anti-inflammatory agent. 24. The method of claim 22, wherein the non-opioid analgesic is aspirin, ibuprofen, diclofenac, naproxen, benoxaprofen, flurbiprofen, fenoprofen, flubufen, ketoprofen, indoprofen, piroprofen, carprofen, oxaprozin, pramoprofen, muroprofen, trioxaprofen, suprofen, aminoprofen, tiaprofenic acid, fluprofen, bucloxic acid, indomethacin, sulindac, tolmetin, zomepirac, tiopinac, zidometacin, acemetacin, fentiazac, clidanac, oxpinac, mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, tolfenamic acid, diflurisal, flufenisal, piroxicam, sudoxicam, isoxicam, or pharmaceutically acceptable salts thereof. 25. A pharmaceutical composition comprising about 0.01 mg to about 250 mg of a compound of formula ##STR00231## or a pharmaceutically acceptable salt thereof. 26. The pharmaceutical composition of claim 25, wherein the pharmaceutical composition comprises 0.1 mg to 200 mg of the compound, or a pharmaceutically acceptable salt thereof. 27. The pharmaceutical composition of claim 25, wherein the pharmaceutical composition comprises 0.15 mg to 4 mg of the compound, or a pharmaceutically acceptable salt thereof. 28. The pharmaceutical composition of claim 25, wherein the pharmaceutical composition is suitable for parenteral administration. 29. The pharmaceutical composition of claim 26, wherein the pharmaceutical composition is suitable for parenteral administration. 30. The pharmaceutical composition of claim 27, wherein the pharmaceutical composition is suitable for parenteral administration. 31. The pharmaceutical composition of claim 25, wherein the pharmaceutical composition is suitable for intravenous administration. 32. The pharmaceutical composition of claim 26, wherein the pharmaceutical composition is suitable for intravenous administration. 33. The pharmaceutical composition of claim 27, wherein the pharmaceutical composition is suitable for intravenous administration.